clinical trial · NCT07237516
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
University of North Carolina, Chapel Hill·—·recruiting·n = 200
Ulcerative Colitis (UC)Crohn's Disease (CD)Indeterminate ColitisInflammatory Bowel Disease (IBD)
brief summary
The goal of this observational study is to learn about how effective Zymfentra (IFX=dyyb) is when treating patients with Crohn's disease (CD) and ulcerative colitis (UC) Does Zymfentra lead to a reduction in symptoms at intervals throughout one year? Participants being prescribed Zymfentra (IFX-dyyb as part of their regular medical care for CD or UC will answer online survey questions about their bowel habits for 1 year.
started
Nov 20, 2025
primary completion
Nov 3, 2028
completion
Nov 3, 2028
last updated
Mar 17, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol